Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Declares Quarterly Dividend of $0.24

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) declared a quarterly dividend on Monday, February 23rd. Shareholders of record on Tuesday, March 31st will be paid a dividend of 0.24 per share by the medical equipment provider on Thursday, April 30th. This represents a c) annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, March 31st.

Zimmer Biomet has a dividend payout ratio of 11.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Zimmer Biomet to earn $8.87 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.8%.

Zimmer Biomet Stock Up 0.6%

Shares of ZBH stock traded up $0.64 during mid-day trading on Monday, reaching $99.39. 1,532,346 shares of the company’s stock traded hands, compared to its average volume of 2,388,878. The company’s 50-day moving average price is $90.64 and its 200-day moving average price is $95.88. The company has a market cap of $19.70 billion, a P/E ratio of 28.08, a P/E/G ratio of 2.02 and a beta of 0.62. The company has a quick ratio of 1.10, a current ratio of 1.98 and a debt-to-equity ratio of 0.55. Zimmer Biomet has a 12 month low of $84.59 and a 12 month high of $114.44.

Zimmer Biomet (NYSE:ZBH) last issued its quarterly earnings results on Tuesday, February 10th. The medical equipment provider reported $2.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.04. The company had revenue of $2.24 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Zimmer Biomet had a net margin of 8.56% and a return on equity of 12.93%. Zimmer Biomet’s revenue was up 10.9% on a year-over-year basis. During the same period last year, the company posted $2.31 EPS. Zimmer Biomet has set its FY 2026 guidance at 8.300-8.450 EPS. On average, equities analysts expect that Zimmer Biomet will post 8.22 earnings per share for the current fiscal year.

About Zimmer Biomet

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.